Parathyroid hormone (PTH) monitoring that can differentiate between oxidized and nonoxidized forms of the substance is expected to improve the treatment of patients with end-stage renal disease (ESRD) ...

We describe two cases of acquired parathyroid hormone (PTH) resistance consequent to the development of serum PTH type 1 receptor (PTH1R) autoantibodies, which block PTH binding and signaling. Both ...

TAMPA, Fla. (WFLA) – Doctors are raising awareness about a disease that often comes with vague symptoms. Parathyroid disease is diagnosed in hundreds of thousands of Americans every year. The disorder ...

November 5, 2007 (San Francisco) — A number of assays that test for intact parathyroid hormone levels (iPTH) are not appropriate for use with the National Kidney Foundation's Kidney Disease Outcomes ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

Parathyroid carcinoma is a rare malignancy, representing 0.005% of all cancers and 0.5%-1% of all parathyroid disorders. Parathyroid carcinoma occurs equally in males and females, as opposed to ...

Orlando M. Gutiérrez, MD The management of chronic kidney disease-mineral bone disorder (CKD-MBD) is central to the care of patients with kidney disease. HOW TO TAKE THE POST-TEST: To obtain CME ...

Parathyroid carcinoma (PC) is a rare entity with profound oncologic and surgical implications, accounting for < 1% of cases of primary hyperparathyroidism (PHPT). PC typically presents as severe PHPT, ...